Title: Head-to-head comparison of the dual-MEK inhibitor IMM-1-104 versus binimetinib in NRAS mutant melanoma models
Date: January 6, 2022
Presenter: Peter King, Ph.D., Immuneering Vice President, Head of Discovery
Virtual Presentation
Title: Head-to-head comparison of the dual-MEK inhibitor IMM-1-104 versus binimetinib in NRAS mutant melanoma models
Date: January 6, 2022
Presenter: Peter King, Ph.D., Immuneering Vice President, Head of Discovery
Virtual Presentation